Fundraising Fox
/Companies
Sign in

Evolvere BioSciences

YC S24

Oxford, GB · Founded 2021 · 3 employees · 4 known investors

Find your way into Evolvere BioSciences

Sign up to see every warm intro you have to Evolvere BioSciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Evolvere BioSciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.

AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryArtificial IntelligenceTherapeuticsBiotechnologyUnited KingdomEurope

Founders & leadership· Y Combinator alumni (S24)

Evolvere BioSciences was founded in 2021 by Adam Winnifrith, Piotr Jedryszek, and Weronika Slesak.

AWAdam Winnifrith
Adam WinnifrithCEOAdam Winnifrith holds a degree in biochemistry from Oxford and is CEO and co-founder of Evolvere BioSciences, where he works on bioengineering, protein AI, and automation technologies.
PJPiotr Jedryszek
Piotr JedryszekCTOPiotr Jedryszek is co-founder and CTO of Evolvere BioSciences, with a background in biology and computational biology.
WSWeronika Slesak
Weronika SlesakFounderWeronika Slesak is a biologist educated at Oxford who currently serves as Chief Scientific Officer at Evolvere BioSciences, where she applies evolutionary principles to bioengineering.

Investors · 4

Agrolimen Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Cleo CapitalreportedNew York · $100K – $1M

How we know: Y Combinator's founder network · Not right? Tell us

James Beshara FundreportedVenice

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Paceline BioPlay Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.
SFA TherapeuticsSFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases. The company's lead program, SFA-002, is in Phase 2 development for plaque psoriasis, with additional pipeline assets targeting pancreatic cancer, liver cancer, rheumatoid arthritis, and inflammatory bowel disease.
Sensible BiotechnologiesSensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.
AlixiaAlixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.
Atlas DiscoveryAtlasDiscovery develops foundation models of patient drug response trained on pre-clinical and clinical data to improve drug trial design and success rates. The company serves pharmaceutical and biotech firms by predicting human drug responses and enabling drug rescue and development in the biotech industry.

Companies working in the same space as Evolvere BioSciences.

Legal entities · 1

corporate structure
Evolvere BioSciences, Inc.

Frequently asked questions

What does Evolvere BioSciences do?
Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.
Who founded Evolvere BioSciences?
Evolvere BioSciences was founded by Adam Winnifrith, Piotr Jedryszek, Weronika Slesak in 2021.
Who are Evolvere BioSciences's investors?
Evolvere BioSciences's investors include Y Combinator, Agrolimen Ventures, Cleo Capital, James Beshara Fund.
Where is Evolvere BioSciences headquartered?
Evolvere BioSciences is headquartered in Oxford, GB.